Valeant fails to satisfy investors in ‘female viagra’
Sprout shareholders say company has set price too high, not marketing pill properly
Allergan rejects Valeant Pharma’s ‘cut and slash’ takeover
Disappointed Valeant expected to raise cash and stock offer to drive through merger of companies with significant overlap of shareholders
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices